The US Food and Drug Administration (FDA) approved Exact Sciences' next-generation multitarget stool DNA (mt-sDNA) test, Cologuard Plus, for use in adults 45 or older who are at average risk for ...
The FDA has approved the Cologuard Plus test, a next-generation, multitarget stool DNA test approved for patients at an average risk for colorectal cancer. The FDA’s approval was based on findings ...
(RTTNews) - Molecular genetics diagnostic company Mainz Biomed N.V. (MYNZ), on Tuesday, announced the submission of its application to the U.S. Food and Drug Administration or FDA seeking Breakthrough ...
On the basis of its positive clinical studies Mainz Biomed has now defined the final configuration including its novel mRNA biomarkers of the Next Generation Test to be used in pivotal registration ...
The MarketWatch News Department was not involved in the creation of this content. CRC Industries will partner with Western Welding Academy, WWA, to introduce students to careers in the trades. HORSHAM ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback